Home
HelpTest ID SEAG1 Hepatitis B e Antigen, Serum
Specimen Required
Only orderable as part of a profile. For more information see SHEAG / Hepatitis B e Profile.
Patient Preparation: Specimens should not be collected from patients receiving therapy with high biotin (vitamin B7) doses (eg, >5 mg/day) until at least 8 hours following the last biotin administration.
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions:
1. For serum gel tubes, allow blood to clot in an upright position for at least 30 minutes. Within 2 hours of collection, centrifuge and refrigerate.
2. For red top tubes, allow blood to clot in an upright position for at least 60 minutes. Within 2 hours of collection, centrifuge, aliquot serum into a plastic vial, and refrigerate. Clearly label tube as serum from a plain red top tube.
Useful For
Staging of hepatitis B infections when used as a surrogate marker for hepatitis B virus (HBV) replication and infectivity
Monitoring response to therapy in chronic hepatitis B infections (along with HBV DNA, hepatitis B surface [HBs] antigen, and HBs antibody) where seroconversion from hepatitis B e (HBe) antigen to HBe antibody indicates virological response
Method Name
Only orderable as part of a profile. For more information see SHEAG / Hepatitis B e Profile.
Electrochemiluminescence Immunoassay (ECLIA)
Reporting Name
Hepatitis B e Antigen, SSpecimen Type
Serum SSTSpecimen Minimum Volume
See Specimen Required
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Serum SST | Refrigerated (preferred) | 14 days |
| Frozen | 90 days | |
| Ambient | 4 days |
Reference Values
Only orderable as part of a profile. For more information see SHEAG / Hepatitis B e Profile.
Nonreactive
Day(s) Performed
Monday through Friday
Report Available
5 daysPerforming Laboratory
Clinical Pathology Laboratories Inc.Test Classification
This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by the performing lab in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
87350
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| SEAG1 | Hepatitis B e Antigen, S | Not Provided |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| SEAG1 | Hepatitis B e Antigen, S | Not Provided |